PMID- 29049273
OWN - NLM
STAT- MEDLINE
DCOM- 20171023
LR  - 20181113
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 66
IP  - 41
DP  - 2017 Oct 20
TI  - Tdap Vaccination Coverage During Pregnancy - Selected Sites, United States,
      2006-2015.
PG  - 1105-1108
LID - 10.15585/mmwr.mm6641a3 [doi]
AB  - Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine
      is recommended during the third trimester of each pregnancy to provide protection
      to newborns, who are at risk for pertussis-related morbidity and mortality (1).
      As part of its case-control surveillance study of medications and birth defects, 
      the Birth Defects Study of the Slone Epidemiology Center at Boston University
      (the Birth Defects Study) has recorded data on vaccinations received during
      pregnancy since 2006. Among 5,606 mothers of infants without structural birth
      defects in this population (control group), <1% had received Tdap vaccine before 
      2009. By 2012, the percentage of mothers of infants in the control group (control
      infants) who had received Tdap increased to approximately 9%, and then in 2013
      and continuing through 2015, increased markedly, to 28% and 54%, respectively. As
      the prevalence of maternal Tdap vaccination increased, so did the proportion of
      pregnant women who received Tdap in the third trimester, as recommended (94%-100%
      from 2010 to 2015). The vast majority of Tdap vaccinations (96%) were received in
      a traditional health care setting (e.g., the office of the woman's obstetrician
      or primary care physician or her prenatal clinic). Increasing vaccination
      coverage during pregnancy could help reduce the impact of pertussis on infant
      morbidity and mortality.
FAU - Kerr, Stephen
AU  - Kerr S
FAU - Van Bennekom, Carla M
AU  - Van Bennekom CM
FAU - Liang, Jennifer L
AU  - Liang JL
FAU - Mitchell, Allen A
AU  - Mitchell AA
LA  - eng
PT  - Journal Article
DEP - 20171020
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
RN  - 0 (Diphtheria-Tetanus-acellular Pertussis Vaccines)
SB  - IM
MH  - Diphtheria/epidemiology/prevention & control
MH  - Diphtheria-Tetanus-acellular Pertussis Vaccines/*administration & dosage
MH  - Female
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Pregnancy
MH  - Pregnancy Trimesters
MH  - Tetanus/epidemiology/prevention & control
MH  - United States/epidemiology
MH  - Vaccination/*statistics & numerical data
MH  - Whooping Cough/epidemiology/prevention & control
PMC - PMC5689095
EDAT- 2017/10/20 06:00
MHDA- 2017/10/24 06:00
CRDT- 2017/10/20 06:00
PHST- 2017/10/20 06:00 [entrez]
PHST- 2017/10/20 06:00 [pubmed]
PHST- 2017/10/24 06:00 [medline]
AID - 10.15585/mmwr.mm6641a3 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2017 Oct 20;66(41):1105-1108. doi:
      10.15585/mmwr.mm6641a3.